Explore more publications!
Djibouti Health Journal
Submit Press Release

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 31, 2025

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
October 31, 2025

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

Indeterminate GlobeNewswire
Upstream Bio to Participate in Upcoming November Investor Conferences
October 31, 2025

Upstream Bio to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
October 31, 2025

Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award

Indeterminate GlobeNewswire
Immuron Announces Clinical Trial Update
October 31, 2025

Immuron Announces Clinical Trial Update

Indeterminate GlobeNewswire
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
October 31, 2025

Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong

Indeterminate GlobeNewswire
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025
October 31, 2025

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025

Indeterminate GlobeNewswire
NANOBIOTIX annonce un accord stratégique avec HealthCare Royalty pour un montant maximum de 71 millions de dollars et prolonge ainsi son horizon de trésorerie pour une croissance durable
October 31, 2025

NANOBIOTIX annonce un accord stratégique avec HealthCare Royalty pour un montant maximum de 71 millions de dollars et prolonge ainsi son horizon de trésorerie pour une croissance durable

Indeterminate GlobeNewswire
NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
October 31, 2025

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

Indeterminate GlobeNewswire
Corbus Pharmaceuticals Announces Pricing of Public Offering
October 31, 2025

Corbus Pharmaceuticals Announces Pricing of Public Offering

Indeterminate GlobeNewswire
Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg
October 31, 2025

Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg

Indeterminate GlobeNewswire
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025
October 31, 2025

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025

Indeterminate GlobeNewswire
Pediatric Dentistry Expert Dr. Matt Sones Shares Insights on How to Prevent Cavities in Children in HelloNation
October 31, 2025

Pediatric Dentistry Expert Dr. Matt Sones Shares Insights on How to Prevent Cavities in Children in HelloNation

Indeterminate GlobeNewswire
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
October 31, 2025

4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

Indeterminate GlobeNewswire
InnoCare Announces First Patient Dosed in Clinical Trial of Novel ADC ICP-B794 in China
October 31, 2025

InnoCare Announces First Patient Dosed in Clinical Trial of Novel ADC ICP-B794 in China

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions